IGF1 and Alzheimer disease: In the AD group (n = 59), higher baseline IGF-I was found to correlate with lower (better) baseline scores of TMT-B (r = –0.40, p = 0.04) and Stroop test I (r = –0.38, p = 0.049) after adjustment for covariates (Table 4).